1. What does MAH mean? MAH refers to a management system where a pharmaceutical manufacturer authorizes other companies to produce its drugs. MAH is an abbreviation for Marketing Authorization Holder. MAH is different from the conventional OEM model, and the drug manufacturer must obtain approval from the National Medical Products Administration and operate under comprehensive management to gain authorization. drugs have been ensured in terms of quality and safety, giving consumers greater peace of mind.
2. What are the advantages of MAH? MAH drugs have significant cost advantages. Since pharmaceutical manufacturers do not need to build their own factories or purchase equipment, they save on labor and time costs. The quality standards are guaranteed and the production process is regulated, which helps improve the quality and consistency of drugs, giving consumers more trust and peace of mind.
3. Limitations and development of MAH. Although MAH drugs have cost advantages and quality guarantees, MAH is not an ultimate solution to pharmaceutical regulatory issues. There are still some issues to be addressed in the MAH system, such as quality regulation and responsibility tracing between different manufacturers. With the continuous reform and improvement of the National Medical Products Administration, it is believed that the MAH system will also continue to grow and be applied in more fields.
